Matthew Perrone

Four months after U.S. regulators tried to block imports of Elf Bar, the top-selling Chinese disposable e-cigarette remains widely available thanks to a simple but effective tactic: a name change.

Health |
Elf Bar finds an easy way around US vape import ban: a name change

October 13, 2023 at 10:26 a.m.

Four months after U.S. regulators tried to block imports of Elf Bar, the top-selling Chinese disposable e-cigarette remains widely available thanks to a simple but effective tactic: a name change.

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work. The Food and Drug Administration convened an expert panel to review the latest data on phenylephrine. That's found in over-the-counter versions of Sudafed, Dayquil and other cold medicines sold on pharmacy shelves. Drugmakers reformulated their pills and solutions with the ingredient after a 2006 law required an older drug to be moved behind the counter. But researchers have long questioned the ingredient's effectiveness. The FDA advisers say new studies show oral phenylephrine was no better than a placebo at relieving congestion.

Health |
Popular nasal decongestant doesn’t actually relieve congestion, FDA advisers say

September 12, 2023 at 4:55 p.m.

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work. The Food and Drug Administration convened an expert panel to review the...

U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops.

Health |
First over-the-counter birth control pill gets FDA approval

July 13, 2023 at 9:35 a.m.

U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops.

Virginia-based Altria’s $13B Juul investment has lost 95% of its value

July 28, 2022 at 11:54 a.m.

Cigarette maker Altria's $13-billion investment in the troubled vaping company Juul has gone up in smoke — now worth less than 5% of its original value as U.S. regulators move...

All Stories